Previous close | 1.4200 |
Open | 1.4700 |
Bid | 1.5000 x 1300 |
Ask | 1.6000 x 800 |
Day's range | 1.4300 - 1.6350 |
52-week range | 0.5000 - 3.8400 |
Volume | |
Avg. volume | 500,719 |
Market cap | 53.068M |
Beta (5Y monthly) | 0.85 |
PE ratio (TTM) | 6.54 |
EPS (TTM) | 0.2400 |
Earnings date | 09 Nov 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Kin Communications Inc. ("Kin"), a leading full-service investor relations agency, has joined forces with NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen M.D.''), a leader in needle-free drug delivery, to raise funds in order to purchase insulin to be administered and delivered with NuGen M.D's needle-free injection device also known as InsuJet™, to Ukrainian diabetics urgently in need of daily insulin injections to stay alive.